Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Promising results for triple A1/A2A/A2B adenosine receptor antagonist in cancer immunotherapy

April 15, 2021

Shenzhen Targetrx Biotechnology identifies mutant EGFR and HER2 inhibitors

April 15, 2021

New NLRP3 agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

April 15, 2021

LY-3484356 shows efficacy in ESR1 wild-type and mutant xenografts

April 15, 2021

Iterion completes enrollment in phase I/IIa dose-expansion study of tegavivint in desmoid tumors

April 14, 2021

Merck & Co. discovers KRAS G12C mutant inhibitors

April 14, 2021

Accutar Biotechnology synthesizes new androgen receptor degrading PROTACs

April 14, 2021

New PARG inhibitors identified at Ideaya Biosciences

April 14, 2021

First-in-class pan-inhibitor of KDM4 TACH-101 active in multiple cancer models

April 14, 2021

CFT-7455 shows potent tumor regression in IMiD-resistant multiple myeloma xenografts

April 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....